Literature DB >> 11552892

The triple-phase CT image appearance of post-irradiated livers.

S Y Chiou1, R C Lee, K H Chi, J Chia-Hsien Cheng, J H Chiang, C Y Chang.   

Abstract

OBJECTIVE: To evaluate the sequential CT appearance of the liver after hepatic irradiation and to investigate the correlation between CT findings and radiation-induced hepatic injury.
MATERIAL AND METHODS: The triple-phase CT images of 18 patients with hepatocellular carcinomas (HCC) after hepatic irradiation were retrospectively reviewed (in total 41 CT studies). The high-dose region within the liver was defined as the area receiving more than 90% of the prescribed irradiation dose. The mean radiation dose was 55.5 Gy. Density changes and patterns of enhancement in the high-dose region were classified as three types: type I, constant low-density change in all phases; type II, low-density change in both pre-contrast and arterial phases, and iso-density change in the portal phase; type III, low- or iso-density change in the pre-contrast phase, low- or high-density change in the arterial phase, and persistent high-density change in the portal phase. The interval between completion of radiotherapy and the CT examinations ranged from 9 to 469 days, with a mean of 147 days.
RESULTS: Nine of the 41 CT studies presented with type I, 9 with type II, and 16 with type III CT findings. The mean interval between completion of radiotherapy and the appearance of types I, II, and III CT findings were 74, 183, and 220 days, respectively. The interval was significantly shorter for type I findings than for type II and type III. The difference in interval was not significant between type II and type III. A type I finding with constant low-density change in the high-dose region of the liver was the most common pattern of CT findings within the first 3 months after hepatic irradiation. Either types II or III findings were frequently seen after 3 months.
CONCLUSION: The sequential CT appearance and the density changes may indicate correlation with the pathogenesis of veno-occlusive disease.

Entities:  

Mesh:

Year:  2001        PMID: 11552892     DOI: 10.1080/028418501127347115

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.701


  8 in total

1.  Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound--initial results.

Authors:  M Krix; C Plathow; M Essig; K Herfarth; J Debus; H-U Kauczor; S Delorme
Journal:  Eur Radiol       Date:  2005-02-24       Impact factor: 5.315

Review 2.  Computed tomography imaging assessment of postexternal beam radiation changes of the liver.

Authors:  Michael Lock; Ashkan A Malayeri; Omar Y Mian; Nina A Mayr; Joseph M Herman; Simon S Lo
Journal:  Future Oncol       Date:  2016-08-31       Impact factor: 3.404

3.  FDG-Avid Focal Liver Reaction From Proton Therapy in a Patient With Primary Esophageal Adenocarcinoma.

Authors:  Hena S Ahmed; Austin R Pantel; James M Metz; John P Plastaras; Michael D Farwell
Journal:  Clin Nucl Med       Date:  2018-05       Impact factor: 7.794

4.  CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function.

Authors:  N Sanuki-Fujimoto; A Takeda; T Ohashi; E Kunieda; S Iwabuchi; K Takatsuka; N Koike; N Shigematsu
Journal:  Br J Radiol       Date:  2010-12       Impact factor: 3.039

5.  Time-dependent changes in CT of radiation-induced liver injury: a preliminary study in gastric cancer patients.

Authors:  Yaqi Sheng; Qiuxia Wang; Zhen Li; Nannan Zheng; Yigang Pei; Liang Chen; Dayu Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

6.  A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images.

Authors:  Sang Hoon Jung; Jeong Il Yu; Hee Chul Park; Do Hoon Lim; Youngyih Han
Journal:  Radiat Oncol J       Date:  2016-03-30

7.  Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?

Authors:  Guanyu Chen; Dechao Jiao; Sheng Peng; Xi Chen; Yanling Zhang; Letao Lin; Zhihui Zhong; Yong Li; Kaihao Xu; Fujun Zhang
Journal:  Eur Radiol       Date:  2022-08-18       Impact factor: 7.034

8.  Stereotactic body radiotherapy-induced arterial hypervascularity of non-tumorous hepatic parenchyma in patients with hepatocellular carcinoma: potential pitfalls in tumor response evaluation on multiphase computed tomography.

Authors:  Mee Jin Park; So Yeon Kim; Sang Min Yoon; Jong Hoon Kim; Seong Ho Park; Seung Soo Lee; Yedaun Lee; Moon-Gyu Lee
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.